Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells

BMC Cancer201717:630

https://doi.org/10.1186/s12885-017-3620-y

Received: 18 July 2016

Accepted: 28 August 2017

Published: 6 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
18 Jul 2016 Submitted Original manuscript
31 Jan 2017 Reviewed Reviewer Report - Rotraud Wieser
17 May 2017 Reviewed Reviewer Report - Lars Bullinger
17 Jun 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 2
17 Jun 2017 Submitted Manuscript version 2
21 Jun 2017 Reviewed Reviewer Report - Rotraud Wieser
2 Jul 2017 Reviewed Reviewer Report - Lars Bullinger
9 Aug 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 3
9 Aug 2017 Submitted Manuscript version 3
24 Aug 2017 Author responded Author comments - Håkon Reikvam
Resubmission - Version 4
24 Aug 2017 Submitted Manuscript version 4
Publishing
28 Aug 2017 Editorially accepted
6 Sep 2017 Article published 10.1186/s12885-017-3620-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medicine, Haukeland University Hospital
(2)
Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital
(3)
Section for Hematology, Institute of Clinical Science, University of Bergen

Advertisement